chartexchange

Eocene and Barcode Nanotech Report Progress in the Development of Tumor Microenvironment-Targeted Lipid Nanoparticles Formulation of Aramchol

PR Newswire | Nov 16, 2026 8:00 AM EST

A unique proprietary lipid nanoparticles (LNPs) novel formulation of Aramchol has been developed using FDA-approved Lipids The novel formulation is designed to redirect Aramchol's biodistribution to target tumor microenvironment (TME) in liver and GI tumors and selectively inhibit the...

Read original article